Thorac Cardiovasc Surg 2017; 65(S 01): S1-S110
DOI: 10.1055/s-0037-1598944
e-Poster Presentations
Monday, February 13, 2017
DGTHG: e-Poster Basic Science
Georg Thieme Verlag KG Stuttgart · New York

Cardioprotective Effects of Dantrolene and Thymoquinone in H9c2 Cells: Does the Phenotype Matter?

S. Borosch
1   University Hospital Aachen, Department of Thoracic and Cardiovascular Surgery, Aachen, Germany
,
S. Kraemer
1   University Hospital Aachen, Department of Thoracic and Cardiovascular Surgery, Aachen, Germany
,
B. Nosirov
1   University Hospital Aachen, Department of Thoracic and Cardiovascular Surgery, Aachen, Germany
,
S. Habibullo
1   University Hospital Aachen, Department of Thoracic and Cardiovascular Surgery, Aachen, Germany
,
C. Beckers
1   University Hospital Aachen, Department of Thoracic and Cardiovascular Surgery, Aachen, Germany
,
C. Stoppe
2   University Hospital Aachen, Department of Intensive Care Medicine, Aachen, Germany
,
A. Goetzenich
1   University Hospital Aachen, Department of Thoracic and Cardiovascular Surgery, Aachen, Germany
,
R. Autschbach
1   University Hospital Aachen, Department of Thoracic and Cardiovascular Surgery, Aachen, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
03 February 2017 (online)

Objectives: Ischemia reperfusion (IR) injury is characterized by inflammation and oxidative damage. Possible strategies to reduce IR injury are for example preconditioning with hypoxia or volatile anesthetics or treatment with calcium inhibitors like dantrolene or antioxidants. Dantrolene inhibits Ca2+ release from the sarcoplasmic reticulum by antagonizing ryanodine receptors (RyR). A promising antioxidant is thymoquinone (TQ) which is the main active component of N. sativa seed oil. Both substances have already been studied in IR-Langendorff models but extensive in vitro studies to unravel the underlying mechanism are still missing. Therefore we investigated the cardioprotective effects of dantrolene and TQ in differentiated and undifferentiated H9c2 cells in an in vitro ischemia reperfusion model.

Methods: H9c2 cells were cultured to 90% confluence and were then either differentiated with 100 nM retinoic acid (RA) for 7 days in 1% FCS containing medium or left untreated. Differentiated and undifferentiated H9c2 cells were incubated with different concentrations of dantrolene and TQ for 3 hour before stressing the cells. To mimic oxidative stress, cells were subjected to different concentrations of H2O2, depending on the differentiation status. The cell viability was evaluated by performing a MTT assay.

Results: Differentiated H9c2 cells were more sensitive to H2O2 treatment than undifferentiated cells. The optimal concentrations of H2O2 to induce ~50–60% cell death were 850 µM for undifferentiated and 650 µM for RA-differentiated H9c2 cells. Dantrolene as well as TQ were able to reduce the detrimental effect of H2O2 in both differentiated and undifferentiated cells. Treatment with 5 µM dantrolene 3 hour prior to H2O2 treatment increased cell viability by 20% compared with the control group in both phenotypes. Interestingly, the protective effect of 5 µM TQ was only present in differentiated cells and resulted in ~15% increased cell viability compared with control. In undifferentiated H9c2 cells, no protective effect of TQ was observed.

Conclusion: Differentiated H9c2 cells were more sensitive to oxidative stress than undifferentiated cells. Treatment with dantrolene reduced the H2O2-induced cell death independently of the phenotype whereas TQ was only protective in differentiated cells. This indicates that protection by the antioxidant properties of TQ is strictly dependent on a cardiac phenotype while Ca2+ inhibition is not.